MSB 1.09% 90.5¢ mesoblast limited

Novartis walked due to "sub par data"., page-127

  1. 11,233 Posts.
    lightbulb Created with Sketch. 707
    Hmmmm Maybe SI told Novartis that times up - in or out today?

    This may have happened if another suitor came along offering a different deal encompassing other things as well but did not want to wait anymore to get serious.

    Shown the door Novartis softens that blow with 'sub par' response to the media....

    Time will tell who had the better poker hand and who is bluffing.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.